AGP Executive Report
Last update: 11 hours agoPrenatal medicine under scrutiny: A Danish study links acetaminophen (Tylenol) use in pregnancy to smaller reproductive organs in daughters, including ~40% smaller ovarian volume and fewer ovarian follicles, with researchers urging longer follow-up and noting it doesn’t prove cause. Vision genetics advance: Scientists report a newly defined late-onset retinal degeneration tied to EFEMP1 gene variants, affecting peripheral and night vision, published in JAMA Ophthalmology. Cancer drug update with Swiss ties: AstraZeneca’s breast-cancer pill camizestrant (Etcamah) missed its main trial goal for progression-free survival, echoing a prior Roche failure; the setback is described as “manageable.” Public health policy debate: UK MPs rejected a bill to legalise assisted dying for the terminally ill, despite earlier Commons approval. Swiss health-adjacent environment: Switzerland’s tax-cut vote in Vaud (12% cut) is set for Sept. 27, with supporters citing purchasing power and opponents warning of budget strain. Health & safety in the news: Reports also highlight multiple serious bus crashes in Switzerland, with medics responding.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
